Sun Pharma on Thursday reported a 40% growth in consolidated net profit at Rs 2,836 crore, which is higher than the Street estimates of 2,638 crore.
Revenue from operations during the same period increased 6% year-on-year (YoY) to Rs 12,653 crore compared with Rs 11,940 crore in the year-ago period.
Comments
Post a Comment